Vancouver, British Columbia–(Newsfile Corp. – December 13, 2024) – Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced final voting results from its annual general meeting of shareholders held on December 13, 2024 in Vancouver, British Columbia (the “Meeting”). Strong Support for Vext Science,…
Bitcoin and Ethereum ETFs Continue Momentum with Solid Inflows U.S. spot bitcoin and ethereum ETFs enjoyed another positive inflow day bringing in $597.57 million and $273.67 million respectively. The Rise of Bitcoin and Ethereum ETF Inflows Bitcoin and ethereum exchange-traded funds (ETFs) maintained their inflow streak with another day of solid inflows into both ETFs….
12 Days of Holiday Safety: Promoting Preparedness and Safety HOUSTON, Dec. 13, 2024 /PRNewswire/ — As part of a company-wide effort to prepare for extreme weather and the 2025 winter storm season, CenterPoint Energy is launching a new “12 Days of Holiday Safety” campaign. The new holiday campaign will provide important daily winter and holiday…
Shutterstock’s Partnership with Lightricks: A New Era of Data Licensing Empowering AI Through Collaboration In a groundbreaking move, Lightricks, a global leader in AI-powered creative technology, has announced a partnership with Shutterstock, Inc. This partnership marks the beginning of a new data licensing approach that aims to revolutionize the way AI models are trained. By…
Reclaiming Compliance: Spectral AI Regains Nasdaq Listing Rule 5550(b)(2) Requirements The Breakthrough Device Designation In December 2018, Spectral AI’s DeepView® System received the prestigious Breakthrough Device Designation from the U.S. FDA. This innovative system utilizes multi-spectral imaging and advanced algorithms to predict the potential for burn healing. Spectral AI has been at the forefront of…
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against ASP Isotopes Inc. Overview: The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) (NASDAQ:ASPI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934…
Aehr Test Systems, Inc. Investor Alert: Potential Recovery under Federal Securities Laws December 13, 2024 New York, NY / ACCESSWIRE If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment, you may be eligible for a potential recovery under the federal securities laws. Investors who have been affected by this matter are…
Crofelemer Trials and Scientific Showcase Webinar Crofelemer Clinical Efforts Crofelemer is the subject of five clinical efforts – three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies – for the rare disease indications of microvillus inclusion disease (MVID) and/or short bowel syndrome with intestinal failure (SBS-IF) in the US, EU, and/or Middle East/North Africa…
